glutathione therapy from prodrugs to genes Recent advances in prodrug-based nanoparticle therapeutics Synthetic prodrug design enables biocatalytic
Synthetic prodrug design enables biocatalytic activation in mice to elicit tumor growth suppression Nature Communications Frontiers Glutathione S conjugates as prodrugs to target drug resistant tumors Glutathione deficiency induces epigenetic alterations of vitamin D metabolism genes in the livers of high fat diet fed obese mice Scientific Reports Glutathione depleted cyclodextrin pseudo polyrotaxane nanoparticles for anti inflammatory oxaliplatin (IV) prodrug delivery and enhanced colorectal cancer therapy ScienceDirect
Pay in 4 interest-free payments of $6.18 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20



